Traditionally, radiation-induced cardiotoxicity has been studied using cardiac radiation doses rather than functional imaging. We developed artificial intelligence (AI) models based on novel cardiac delta radiomics using pre- and post-treatment FDG-PET/CT scans to predict overall survival in lung cancer patients undergoing radiotherapy. We identified four clinically relevant delta radiomics features with the AI prediction models. The best model achieved an AUC of 0.91 on the training set and 0.87 on the test set. We are a pioneering group in AI for functional cardiac imaging. If validated, this approach will enable to use standard PET/CT scans as functional cardiac imaging with good predictive AUC for OS, as well as provide automated methods to provide functional cardiac information for clinical outcome prediction AI in lung cancer patients.
Novel Deep Learning Segmentation Models for Accurate GTV and OAR Segmentation...Wookjin Choi
More Related Content
Similar to Artificial Intelligence To Reduce Radiation-induced Cardiotoxicity In Lung Cancer Radiotherapy: A Novel Functional Radiomics Using Cardiac FDG-PET/CT
Similar to Artificial Intelligence To Reduce Radiation-induced Cardiotoxicity In Lung Cancer Radiotherapy: A Novel Functional Radiomics Using Cardiac FDG-PET/CT (20)
Artificial Intelligence To Reduce Radiation-induced Cardiotoxicity In Lung Cancer Radiotherapy: A Novel Functional Radiomics Using Cardiac FDG-PET/CT
1. AI to Reduce Radiation-induced Cardiotoxicity in Lung Cancer Radiotherapy:
A Novel Functional Radiomics
using Cardiac FDG-PET/CT
Wookjin Choi, Adam P. Dicker, and Yevgeniy Vinogradskiy
Department of Radiation Oncology,
Sidney Kimmel Medical College / Cancer Center
at Thomas Jefferson University, Philadelphia, PA
2. • Assistant Professor / Computational Medical Physicist
Sidney Kimmel Medical College / Cancer Center at Thomas Jefferson University
• A research grant from ViewRay, Inc.
• A research grant from Varian Medical Systems, Inc.
• A research grant from the PROPEL Center
• Research software license for INT Contour from Carina Medical
• This project was partially supported by the Sidney Kimmel Cancer Center Support Grant
(NIH/NCI P30 CA056036)
2
Disclosure
5. • Radiation has been an effective tool for
treating cancer for more than 100 years
• More than 60 percent of patients diagnosed
with cancer will receive radiation therapy as
part of their treatment
• Radiation oncologists are cancer specialists
who manage the care of cancer patients with
radiation for either cure or palliation
5
Radiation Oncology
Patient being treated with modern
radiation therapy equipment.
6. 6
Advances in Radiation Oncology
Figure 1(b) of Lee et al. "Physical and radiobiological evaluation of radiotherapy treatment plan." Evolution of ionizing radiation research. InTech (2015): 109-50.
7. • Radiation Oncologist prescribes and oversees the radiation therapy treatments
• Medical Physicist ensures that treatment plans are properly tailored for each
patient, and is responsible for the calibration and accuracy of treatment equipment
• Dosimetrist works with the radiation oncologist and medical physicist to calculate
the proper dose of radiation given to the tumor
• Radiation Therapist administers the daily radiation under the doctor’s prescription
and supervision
• Radiation Oncology Nurse interacts with the patient and family at the time of
consultation, throughout the treatment process and during follow-up care
7
The Radiation Oncology Team
8. • Medical physics is easy to define
Application of physics to medicine
• There is a long tradition of using applied physics to improve medicine (both
treatments and diagnostics)
8
Medical Physics
From the early radiographs to the modern medical linear accelerator
9. 9
AI in Radiation Oncology
Huynh et al. Nat Rev Clin Oncol 2020
A general overview of the radiation therapy workflow with brief descriptions of expected applications of AI at each step.
10. Diagnosis Simulation Contouring
Treatment
Planning
Treatment
QA
Treatment
Delivery
MIM Protégé AI &
Auto export to
Eclipse
Auto-contouring
of daily
CBCT/MR
Eclipse
DVH Metric
script
MIM Archive &
Auto export to
RadCalc
AI Dose
Prediction using
Diagnostic
PET/CT
Weekly
Dashboard
Dosimetry
Whiteboard
Longitudinal
Radiomics
Customized AI
Contouring
Current Solutions in Jefferson SKCC Radiation Oncology
10
Cardiac PET
Heart Toxicity
Prediction
Cardiac PET
Heart Toxicity
Assessment
11. Radiomics
11
Aerts et al. Nature Communications, 2014
Figure 1: Extracting radiomics data from images. Figure 2: Analysis workflow.
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
12. • Quantitative approach to medical imaging
• Extracts many features from medical images
• These features can be used to predict prognosis and therapeutic response
• Radiomics has the potential to revolutionize the way we diagnose and treat cancer
12
Radiomics
Fully automated pipeline, Woznicki et al. Frontiers in Radiology 2022 https://github.com/pwoznicki/AutoRadiomics
14. • Traditional methods of evaluating cardiotoxicity:
Focus solely on radiation doses to the heart.
Do not incorporate functional imaging information.
• Functional imaging has potential to improve cardiotoxicity prediction for
lung cancer patients undergoing radiotherapy:
FDG PET/CT imaging is routinely obtained for lung cancer staging.
PET scans can be used to evaluate cardiac inflammation.
Studies indicate that PET cardiac signal can predict clinical outcomes.
• The purpose of this work:
Develop a radiomics model to predict clinical cardiac assessment using FDG PET/CT
scans.
Heart Toxicity Prediction using PET/CT Radiomics for Lung Radiotherapy
14
15. • Pre-Treatment only - before treatment
Dose prediction
Cardiac PET/CT Radiomics to predict existing heart disease
CT coronary artery calcium scoring
Collected TJU 100 pts data and continue to collect more data
70 pts from ACRIN 6668/RTOG 0235, 39 pts from CU/BU
Manual and auto heart contouring
• Pre & Post Treatment – during/after treatment
PET/CT Radiomics
Delta-radiomics between pre and post PET/CT
70 pts from ACRIN 6668/RTOG 0235, 39 pts from CU/BU
Manual and auto heart contouring
15
Heart Toxicity Prediction using PET/CT Radiomics for Lung Radiotherapy
16. 16
AI in Radiation Oncology – Heart Toxicity Prediction
Huynh et al. Nat Rev Clin Oncol 2020
A general overview of the radiation therapy workflow with brief descriptions of expected applications of AI at each step.
Dose Map
Prediction
Cardiac Uptake
Classification
Overall Survival
Prediction
17. Diagnostic PET/CT Radiation Target delineation Normal tissue delineation Radiation dose distribution
Diagnostic PET/CT Radiation dose distribution
AI/ML
Dose Prediction before Treatment Planning
17
18. • The study included 209 pre-treatment 18F-FDG PET-CT images of lung cancer patients from 3
different study populations (TJU: 100, ACRIN: 70, CU: 39).
Low quality images were excluded 7 (TJU: 1, ACRIN: 4, CU:2).
Cardiac PET/CT Radiomics - Dataset
CLASS
LV MYOCARDIAL
UPTAKE PATTERN
TJU ACRIN CU TOTAL
0 Uniform 19 (19.2%) 21 (31.8%) 11 (29.8%) 51 (25.2%)
1 Absent 44 (44.4%) 23 (34.8%) 13 (35.1%) 80 (39.6%)
2 Heterogeneous 36 (36.4%) 22 (33.3%) 13 (35.1%) 71 (35.1%)
ALL 99 (100.0%) 66 (100.0%) 37 (100.0%) 202 (100.0%)
Table 1. Statistics of LV FDG Uptake Pattern Classification
Figure 2. Cardiac uptake classifications, Uniform, Absent, and Heterogeneous (Non-uniform and Focal )
18
19. 19
Method - Study Flow Diagram
Figure 1. Study and cardiac model diagram, training dataset: TJU (N=99), and external validation data sets: ACRIN (N=66) and CU (N=37).
RFE: Recursive Feature Elimination, SFS: Sequential Feature Selection
1. Pre-processing
LV FDG uptake patter
review
By Radiation Oncologist
Manual
Heart Contouring
By Medical Physicist
Automatic
Heart Contouring
By 1Commercial Software
Training
Data set
(N=99)
2. Feature Analysis
Feature Extraction
- PyRadiomics
- In-house SW
Feature Reduction
- Wilcoxon test
- Clustering
Feature Selection
- RFE
- SFS
3. Model Building
Model Exploration
- TPOT
Optimization
- Hyper-parameters
- Feature Selection
Evaluation
- Validation
- External validation
Predicted
LV Uptake
Pattern
External
Validation
Data sets
(N=103)
1INTContour, Carina Medical https://www.carinaai.com/intcontour.html
20. • Training and Validation Data:
Training dataset: TJU (N=100), 80% training set (TPOT optimization), 20% validation set.
External validation datasets: ACRIN (N=70), CU (N=39)
• Radiomics Feature Extraction
Heart delineation: Manual and Auto
Selected 200 novel functional radiomics features – In-house: 103, PyRadiomics: 97
Feature categories include Shape (2D and 3D), First-order (2D and 3D), GLCM, GLSZM, GLRLM, NGTDM,
GLDM.
• Feature Reduction
Feature robustness test using ICC between features from Auto and Manual delineations
Wilcoxon test (Bonferroni adjusted p<0.05)
Hierarchical clustering
Method – Radiomics Feature Extraction and Reduction
20
21. 21
Results: Pipeline Optimization using TPOT
Feature Selector
Variance Threshold
Threshold: 0.0001
56 features
Threshold: 0.005
52 features
RFE ranking and
SFS with TPOT optimization
Top 9 features
Feature Transformer
One Hot Encoder
Minimum_fraction: 0.15,
Sparse: False,
Threshold: 10
Minimum_fraction: 0.25
Minimum_fraction: 0.15
Classifier
Extra Trees Classifier
Bootstrap: False,
criterion: gini,
max_features: 0.95,
min_samples_leaf: 3,
min_samples_split: 20
Criterion: entropy,
max_features: 0.75,
min_samples_leaf: 2,
min_samples_split: 17
Bootstrap: True,
criterion: gini,
max_features: 0.8,
min_samples_split: 10
Model
Discovery
Hyper-
parameter
Optimization
Feature
Optimization
Validation Accuracy (%)
TJU ACRIN CU
90.0 78.8 90.2
90.0 78.8 91.9
95.0 80.3 91.9
22. • TPOT (Tree-Based Pipeline Optimization Tool)
100 populations, 10 generations, 10-fold CV
Evaluated 10,000 pipeline configurations to identify the best model.
• Pipeline Construction
Three component template: Feature Selector—Feature Transformer—Classifier
o Feature Selector: P-value (ANOVA F-statistic), Family Wise Error Rate, Percentile, Low-Variance Feature Removal, RFE
with Extra Trees Classifier
o Feature Transformer: Binarization, ICA, Feature Agglomeration (Various Linkage & Affinity Methods), Scaling (Max
Absolute Value, Min-Max Values), Normalization (l1, l2, max norm) ,Kernel Approximation (RBF, Cosine, χ2, etc.), PCA,
Polynomial Features, RBF Sampler, Robust Scaler, Standard Scaler, Zero Count, One Hot Encoder
o Classifier: Naïve Bayesian (Bernoulli, Multinomial), Decision Tree Classifier, Extra Trees Classifier, Random Forest
Classifier, Gradient Boosting Classifier, XGBoost, KNN Classifier, Linear SVM Classifier, Logistic Regression, SGD, MLP
• Hyper-parameter Optimization: optimize parameters of the discovered pipeline
• Feature Optimization: Utilized RFE for feature ranking followed by SFS with TPOT optimization.
Method - Machine Learning Model Pipeline Selection and Optimization
22
23. Results – Feature reduction and Prediction results
Model iteration and explanation
Number of
features
10-fold cross
validation
accuracy (%)
Training
accuracy (%)
Validation
accuracy (%)
External
Validation
accuracy -
ACRIN (%)
External
Validation
accuracy – CU
(%)
Iteration 1:
Model discovery 56 88.9 94.9 90.0 78.8 89.2
Iteration 2:
Hyperparameter optimization
52 89.9 96.2 90.0 78.8 91.9
Iteration 3:
Feature optimization 9 89.8 92.4 95.0 80.3 91.9
9 Selected Features: 2D Maximum, 2D Skewness, Mean, GLCM Cluster Prominence, GLCM Sum
Average, GLCM Cluster Shade, GLDM Dependence Variance, Maximum, 2D Kurtosis
Feature reduction The number of remaining Features
ICC 153
Wilcoxon Test 141
Hierarchical Clustering 62
Table 3. Model pipeline optimization results and validation results.
Table 2. Feature reduction results
23
24. • Delta-Radiomics calculation:
The change between pre- and post-PET/CT.
Difference Δ𝐹𝑖
= 𝐹𝑝𝑜𝑠𝑡
𝑖
− 𝐹𝑝𝑟𝑒
𝑖
𝐹: the feature vector, 𝑖: the index of the feature vector
• The study identified four clinically relevant delta-
radiomics features
Pre-CT Maximum
Post-CT Minimum
Delta-CT GLRM Run Variance
Delta-PET GLRM Run Entropy
• Model performance
CV on the training set: 0.91 AUC
The test set: 0.87 AUC
24
Results - Overall survival prediction using delta radiomics Pre & Post
Figure 1: Example of patients with variable pre and post-treatment
cardiac PET/CT signal.
Vinogradskiy Y, Diot Q, Jones B, et al. Evaluating Positron Emission Tomography-
Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients
With Lung Cancer. International Journal of Radiation Oncology* Biology* Physics.
2020;106(5):1063-1070.
25. • Utilized dataset of 209 patients for functional cardiac radiomics model
development.
• Achieved high accuracy:
9 optimal features were selected
Training set validation: TJU: 95%
External validation : ACRIN: 80.3%, CU: 91.1%
• Clinical Application:
Automated prediction of existing cardiac conditions.
Early biomarker for post-radiotherapy cardiac complications.
Conclusion
25
Most recent advances aim to:
Better see the tumor target
Better focus radiation doses on small targets
Improve sparing of surrounding tissues to reduce side effects
The radiation therapy treatment team works closely to ensure that patients are receiving safe, quality treatment.
Best described as the application of physics concepts, theories, and principles to medicine or healthcare
Responsible for the technical foundations of radiology, radiation oncology, and nuclear medicine
Built on foundation of physics, but with distinct body of knowledge and scholarship
Distinct from biophysics
Incorporates both theoretical and experimental methods, but inherently an applied discipline
The workflow begins with the decision to treat the patient with radiation therapy,
followed by a simulation appointment during which medical images are acquired for treatment planning.
Subsequently, the patient-specific treatment plan is created,
and then the plan is subjected to approval, review and quality assurance (QA) measures prior to delivery of radiation to the patient.
The patient then receives follow-up care.
AI has the potential to improve radiation therapy for patients with cancer by increasing efficiency for the staff involved, improving the quality of treatments, and providing additional clinical information and predictions of treatment response to assist and improve clinical decision-making.
Human cancers exhibit strong phenotypic differences that can be visualized noninvasively by medical imaging. Radiomics refers to the comprehensive quantification of tumour phenotypes by applying a large number of quantitative image features. Here we present a radiomic analysis of 440 features quantifying tumour image intensity, shape and texture, which are extracted from computed tomography data of 1,019 patients with lung or head-and-neck cancer. We find that a large number of radiomic features have prognostic power in independent data sets of lung and head-and-neck cancer patients, many of which were not identified as significant before. Radiogenomics analysis reveals that a prognostic radiomic signature, capturing intratumour heterogeneity, is associated with underlying gene-expression patterns. These data suggest that radiomics identifies a general prognostic phenotype existing in both lung and head-and-neck cancer. This may have a clinical impact as imaging is routinely used in clinical practice, providing an unprecedented opportunity to improve decision-support in cancer treatment at low cost.
Figure 1: Extracting radiomics data from images.
(a) Tumours are different. Example computed tomography (CT) images of lung cancer patients. CT images with tumour contours left, three-dimensional visualizations right. Please note strong phenotypic differences that can be captured with routine CT imaging, such as intratumour heterogeneity and tumour shape. (b) Strategy for extracting radiomics data from images. (I) Experienced physicians contour the tumour areas on all CT slices. (II) Features are extracted from within the defined tumour contours on the CT images, quantifying tumour intensity, shape, texture and wavelet texture. (III) For the analysis the radiomics features are compared with clinical data and gene-expression data.
Figure 2: Analysis workflow.
The defined radiomic features algorithms were applied to seven different data sets. Two data sets were used to calculate the feature stability ranks, RIDER test/retest and multiple delineation respectively (both orange). The Lung1 data set, containing data of 422 non-small cell lung cancer (NSCLC) patients, was used as training data set. Lung2 (n=225), H&N1 (n=136) and H&N2 (n=95) were used as validation data sets. The Lung3 data set (n=89) was used for association of the radiomic signature with gene expression profiles. For the multivariate analysis, only one fixed four-feature radiomic signature was tested in the validation data sets.
Standard Staging: FDG PET-CT imaging is routinely used as part of the standard staging method for cancer patients.
Cardiac Complications: Cancer therapy can result in cardiac complications, making early detection and management crucial.
RTOG 0617 was the first study that highlighted the issue of cardiac dose in lung cancer radiotherapy.
The original article revealed that the volume of heart receiving greater than or equal to 5 Gy (V5) or greater than or equal to 30 Gy (V30) was associated with worse overall survival.
The workflow begins with the decision to treat the patient with radiation therapy,
followed by a simulation appointment during which medical images are acquired for treatment planning.
Subsequently, the patient-specific treatment plan is created,
and then the plan is subjected to approval, review and quality assurance (QA) measures prior to delivery of radiation to the patient.
The patient then receives follow-up care.
AI has the potential to improve radiation therapy for patients with cancer by increasing efficiency for the staff involved, improving the quality of treatments, and providing additional clinical information and predictions of treatment response to assist and improve clinical decision-making.
gray level co-occurrence matrix (GLCM), gray level size zone matrix (GLSZM), gray level run length matrix (GLRLM), neighboring gray tone difference matrix (NGTDM), gray level dependence matrix (GLDM), and 2D and 3D shape features.
gray level co-occurrence matrix (GLCM), gray level size zone matrix (GLSZM), gray level run length matrix (GLRLM), neighboring gray tone difference matrix (NGTDM), gray level dependence matrix (GLDM), and 2D and 3D shape features.